Abstract
The use and adherence monitoring of opioids in pain management is recommended by numerous clinical practice guidelines. Many physicians use urine immunoassay screening tests, which suffer from a lack of sensitivity and specificity, to verify compliance to pain medications. However, several immunoassay tests are required to comprehensively detect the synthetic, semisynthetic, and natural opioids due to the limited cross-reactivity of each assay. Superior testing strategies are required to specifically identify low concentrations of opioids found in adherent pain management patients. Therefore we present a method for the qualitative identification of 33 opioids and metabolites (codeine, codeine-6-β-glucuronide, morphine, morphine-6-β-glucuronide, 6-acetylmorphine, hydrocodone, norhydrocodone, dihydrocodeine, hydromorphone, hydromorphone-3-β-glucuronide, oxycodone, noroxycodone, oxymorphone, oxymorphone-3-β-glucuronide, noroxymorphone, meperidine, normeperidine, methadone, EDDP, propoxyphene, norpropoxyphene, tramadol, O-desmethyltramadol, tapentadol, tapentadol-β-glucuronide, N-desmethyltapentadol, buprenorphine, norbuprenorphine, norbuprenorphine glucuronide, naloxone, naloxone glucuronide, fentanyl, and norfentanyl) in unhydrolyzed urine using a liquid chromatography tandem mass spectrometry (LC-MS/MS) with high-resolution, accurate-mass Orbitrap detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Owen GT, Burton AW, Schade CM, Passik S (2012) Urine drug testing: current recommendations and best practices. Pain Physician 15:ES119–ES133
Centers For Disease Control And Prevention Public Health Service U S Department Of Health And Human Services (2016) Centers for disease control guideline for prescribing opioids for chronic pain—United States. http://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6501e1.pdf. Accessed 15 Jun 2017
Gutstein HB, Akil H (2006) Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL (eds) The pharmacological basis of therapeutics, 11th edn. McGraw-Hill Companies Inc., Goodman & Gilman’s http://www.accessmedicine.com/content.aspx?aID=940653
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Danso, D., Langman, L.J., Jannetto, P.J. (2019). Targeted Opioid Screening Assay for Pain Management Using High-Resolution Mass Spectrometry. In: Langman, L., Snozek, C. (eds) LC-MS in Drug Analysis. Methods in Molecular Biology, vol 1872. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8823-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8823-5_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8822-8
Online ISBN: 978-1-4939-8823-5
eBook Packages: Springer Protocols